Phylogica signs Roche deal

Perth-based drug discovery company Phylogica has signed an agreement with pharmaceuticals maker Roche to evaluate Phylogica's proprietary Phylomer technology in transporting large molecules to attack disease targets within cells.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer